Bioelectronics Corp (BIEL)

[srinsocal]

This conversation got me thinking about Bioboosti, something found several years ago, PEMF based device in China that partnered with insurance companies. Biomobie Company founder Jack Wang proved to clients that his PEMF device, Bioboosti, worked and negotiated an efficient way to sell millions of devices.

"Instead of going through the hospitalization route, which is a bit complicated, we decided to go down the preventative route."

"We, therefore, decided to approach insurance companies to finance the device’s use, and this business model started in 2019. As our device can both alleviate chronic conditions and prevent them, insurance companies can potentially save millions of dollars. We have already signed contracts with major insurance companies like PingAn Insurance, Taiping Insurance and Taikang Insurance. Whereas before insurance companies might refuse to sell insurance to people with high blood pressure or other pre-existing conditions, they will now sell a bundled insurance package under the condition that they use Bioboosti every day, and the usage will be monitored through an app."

"The corporate world is also interested in this idea to manage the health of their employees. One of the largest Chinese banks is going to be covering its 300,000 employees with such a bundled insurance package. Not all of them are going to be using Bioboosti, only the ones at risk – and when they use it, their rates will go down."

The Bioboosti is a more sophisticated PEMF device than ActiPatch but the principle of PEMF use lowering healthcare costs, as Dr. Staelin showed in his UK Study, is similar.

https://pharmaboardroom.com/interviews/jack-wang-founder-ceo-biomobie-china/
http://en.biomobie.com/principle.htm